Several major pharmaceutical companies are key players in the drug delivery market.
3 reports, 2 independent
Updated Oct 16
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Several major pharmaceutical companies are key players in the drug delivery market.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- AbbVie, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca participated in drug delivery innovation discussions and partnerships.Sub-event
Major pharma companies identified as key players in the drug delivery market.1 source
Keep exploring
The entities involved
-
Bristol-Myers Squibb
American pharmaceutical company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
GlaxoSmithKline
company in Tokyo, Japan
Related events
- Bristol-Myers Squibb and Novo Nordisk are noted as competitors in the healthcare sector.
- AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.
- Major pharmaceutical companies are competing for investment capital.
- A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
- Johnson & Johnson is co-commercializing the prescription medicine IMBRUVICA with Pharmacyclics, a subsidiary of AbbVie.
Coverage
Newest first; wire copies grouped- fool.com
- fool.com
- GlobeNewswire[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Gro